COST-EFFECTIVENESS OF ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B: A SYSTEMATIC REVIEW

被引：1
|
作者：
Chen, W. [1 ]
Tang, Z. [2 ]
Wang, X. [2 ]
Li, J. [3 ]
Luo, Z. [3 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Bristol Myers Squibb Co, Shanghai, Peoples R China
[3] Normin Hlth Changsha Representat Off, Changsha, Hunan, Peoples R China
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.518
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN18
引用
收藏
页码：A805 / A805
页数：1
相关论文
共 50 条
  • [21] Cost-Effectiveness Analysis of Antiviral Therapies for Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients in China
    Chi Zhang
    Weixia Ke
    Yanhui Gao
    Shudong Zhou
    Li Liu
    Xiaohua Ye
    Zhenjiang Yao
    Yi Yang
    Clinical Drug Investigation, 2015, 35 : 197 - 209
  • [22] Cost-Effectiveness Analysis of Antiviral Therapies for Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients in China
    Zhang, Chi
    Ke, Weixia
    Gao, Yanhui
    Zhou, Shudong
    Liu, Li
    Ye, Xiaohua
    Yao, Zhenjiang
    Yang, Yi
    CLINICAL DRUG INVESTIGATION, 2015, 35 (03) : 197 - 209
  • [23] EFFECTIVENESS AND COST-EFFECTIVENESS OF HEPATITIS C SCREENING-A SYSTEMATIC REVIEW
    Sroczynski, G.
    Esteban, E.
    Conrads-Frank, A.
    Schwarzer, R.
    Muehlberger, N.
    Wright, D. R.
    Zeuzem, S.
    Siebert, U.
    VALUE IN HEALTH, 2008, 11 (06) : A437 - A438
  • [24] COST-EFFECTIVENESS OF PROTEASE INHIBITORS FOR THE TREATMENT OF CHRONIC HEPATITIS C INFECTION: A SYSTEMATIC REVIEW
    Silva, N.
    Espinoza, M. A.
    VALUE IN HEALTH, 2014, 17 (03) : A276 - A276
  • [25] Efficacy and cost-effectiveness of antiviral regimens for entecavir-resistant hepatitis B: A systematic review and network meta-analysis
    Si-Si Yang
    Cheng-Wei Cai
    Xue-Qing Ma
    Jia Xu
    Cheng-Bo Yu
    Hepatobiliary & Pancreatic Diseases International, 2020, 19 (06) : 507 - 514
  • [26] Efficacy and cost-effectiveness of antiviral regimens for entecavir-resistant hepatitis B: A systematic review and network meta-analysis
    Yang, Si-Si
    Cai, Cheng-Wei
    Ma, Xue-Qing
    Xu, Jia
    Yu, Cheng-Bo
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2020, 19 (06) : 507 - 514
  • [27] Cost-effectiveness in hepatitis B
    Weitzman, G
    Jacobson, I
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (10) : 757 - 758
  • [28] A cost-effectiveness model to personalize antiviral therapy in naive patients with genotype 1 chronic hepatitis C
    Iannazzo, Sergio
    Colombatto, Piero
    Ricco, Gabriele
    Oliveri, Filippo
    Bonino, Ferruccio
    Brunetto, Maurizia R.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (03) : 249 - 254
  • [29] A systematic review of cost-effectiveness analyses of gene therapy for hemophilia type A and B
    Alshehri, Alaa
    Dougherty, John A.
    Beckman, Linda
    Svensson, Mikael
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (10): : 1178 - 1188
  • [30] Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation
    Zhang, Sihui
    Wang, Chao
    Liu, Bei
    Lu, Qing-Bin
    Shang, Jia
    Zhou, Yihua
    Jia, Jidong
    Xu, Xiaoyuan
    Rao, Huiying
    Han, Bingfeng
    Zhao, Tianshuo
    Chen, Linyi
    Xie, Mingzhu
    Cui, Jiahao
    Du, Juan
    Zeng, Jing
    Huang, Ninghua
    Liu, Yaqiong
    Zhang, Lei
    Zhuang, Hui
    Cui, Fuqiang
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 35
12345